BioHarvest Sciences and Saffron Tech Forge Strategic CDMO Partnership to Revolutionize Botanical Synthesis
Vancouver, British Columbia & Rehovot, Israel — October 30, 2025 — BioHarvest Sciences Inc. (NASDAQ: BHST) has announced a...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Vancouver, British Columbia & Rehovot, Israel — October 30, 2025 — BioHarvest Sciences Inc. (NASDAQ: BHST) has announced a...
